The identification of Parkinson's disease subtypes using cluster analysis: a systematic review
The clinical variability between patients with Parkinson's disease (PD) may point at the
existence of subtypes of the disease. Identification of subtypes is important, since a focus on …
existence of subtypes of the disease. Identification of subtypes is important, since a focus on …
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
MA Van Es, HJ Schelhaas, PWJ Van Vught… - Annals of …, 2011 - Wiley Online Library
Objective: Several studies have suggested an increased frequency of variants in the gene
encoding angiogenin (ANG) in patients with amyotrophic lateral sclerosis (ALS) …
encoding angiogenin (ANG) in patients with amyotrophic lateral sclerosis (ALS) …
Age determination of subdural hematomas with CT and MRI: a systematic review
T Sieswerda-Hoogendoorn, FAM Postema… - European journal of …, 2014 - Elsevier
Objectives To systematically review the literature on dating subdural hematomas (SDHs) on
CT and MRI scans. Methods We performed a systematic review in MEDLINE, EMBASE and …
CT and MRI scans. Methods We performed a systematic review in MEDLINE, EMBASE and …
Patient-reported autonomic symptoms in Parkinson disease
D Verbaan, J Marinus, M Visser, SM van Rooden… - Neurology, 2007 - AAN Enterprises
Objective: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD),
but the full spectrum has never been evaluated with a validated instrument and in …
but the full spectrum has never been evaluated with a validated instrument and in …
Cognitive impairment in Parkinson's disease
D Verbaan, J Marinus, M Visser… - Journal of Neurology …, 2007 - jnnp.bmj.com
Background: Cognitive impairment plays a role in Parkinson's disease (PD) and has
important consequences for patient management. However, many aspects of cognitive …
important consequences for patient management. However, many aspects of cognitive …
Clinical subtypes of Parkinson's disease
SM van Rooden, F Colas, P Martínez‐Martín… - Movement …, 2011 - Wiley Online Library
The clinical heterogeneity of Parkinson's disease (PD) may point at the existence of
subtypes. Because subtypes likely reflect distinct underlying etiologies, their identification …
subtypes. Because subtypes likely reflect distinct underlying etiologies, their identification …
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
RJ Molenaar, D Verbaan, S Lamba, C Zanon… - Neuro …, 2014 - academic.oup.com
Background Genetic and epigenetic profiling of glioblastomas has provided a
comprehensive list of altered cancer genes of which only O6-methylguanine …
comprehensive list of altered cancer genes of which only O6-methylguanine …
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial
R Post, MR Germans, MA Tjerkstra, MDI Vergouwen… - The Lancet, 2021 - thelancet.com
Background In patients with aneurysmal subarachnoid haemorrhage, short-term
antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding …
antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding …
Nighttime sleep problems and daytime sleepiness in Parkinson's disease
D Verbaan, SM van Rooden, M Visser… - Movement …, 2008 - Wiley Online Library
Our objective is to evaluate nighttime sleep problems (NSP) and daytime sleepiness (DS) in
patients with Parkinson's disease (PD) compared to controls, and to assess relations with …
patients with Parkinson's disease (PD) compared to controls, and to assess relations with …
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease
S Boesveldt, D Verbaan, DL Knol… - … : official journal of the …, 2008 - Wiley Online Library
The aim of this study was to compare the characteristics of odor discrimination and odor
identification deficits in a large population of patients with Parkinson's disease (PD) and to …
identification deficits in a large population of patients with Parkinson's disease (PD) and to …